143 related articles for article (PubMed ID: 32106339)
21. Discontinuation of Oral Antiplatelet Agents before Dental Extraction - Necessity or Myth?
Dinkova AS; Atanasov DT; Vladimirova-Kitova LG
Folia Med (Plovdiv); 2017 Sep; 59(3):336-343. PubMed ID: 28976895
[TBL] [Abstract][Full Text] [Related]
22. Edoxaban administration following enoxaparin: a pharmacodynamic, pharmacokinetic, and tolerability assessment in human subjects.
Zahir H; Matsushima N; Halim AB; He L; Zhang G; Lee F; Worland V; Mendell J
Thromb Haemost; 2012 Jul; 108(1):166-75. PubMed ID: 22628060
[TBL] [Abstract][Full Text] [Related]
23. Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.
Brouwer J; Nijenhuis VJ; Delewi R; Hermanides RS; Holvoet W; Dubois CLF; Frambach P; De Bruyne B; van Houwelingen GK; Van Der Heyden JAS; Toušek P; van der Kley F; Buysschaert I; Schotborgh CE; Ferdinande B; van der Harst P; Roosen J; Peper J; Thielen FWF; Veenstra L; Chan Pin Yin DRPP; Swaans MJ; Rensing BJWM; van 't Hof AWJ; Timmers L; Kelder JC; Stella PR; Baan J; Ten Berg JM
N Engl J Med; 2020 Oct; 383(15):1447-1457. PubMed ID: 32865376
[TBL] [Abstract][Full Text] [Related]
24. Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin.
Davidson BL; Verheijen S; Lensing AW; Gebel M; Brighton TA; Lyons RM; Rehm J; Prins MH
JAMA Intern Med; 2014 Jun; 174(6):947-53. PubMed ID: 24733305
[TBL] [Abstract][Full Text] [Related]
25. Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers.
Ollier C; Faaij RA; Santoni A; Duvauchelle T; van Haard PM; Schoemaker RC; Cohen AF; de Greef R; Burggraaf J
Clin Pharmacokinet; 2002; 41 Suppl 2():31-7. PubMed ID: 12383043
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and bioequivalence of low-dose clopidogrel in healthy Chinese volunteers under fasted and fed conditions.
Gong L; Fu C; Bi L; Kuang Y; Guo C; Wei G; Yan Z; Huang J; Yang G
Drug Metab Pharmacokinet; 2019 Oct; 34(5):300-307. PubMed ID: 31239099
[TBL] [Abstract][Full Text] [Related]
27. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
[TBL] [Abstract][Full Text] [Related]
28. Impact of the Chinese herbal medicines on dual antiplatelet therapy with clopidogrel and aspirin: Pharmacokinetics and pharmacodynamics outcomes and related mechanisms in rats.
Xiao M; Qian C; Luo X; Yang M; Zhang Y; Wu C; Mok C; Lee P; Zuo Z
J Ethnopharmacol; 2019 May; 235():100-110. PubMed ID: 30710735
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
[TBL] [Abstract][Full Text] [Related]
30. The pharmacokinetics and safety of a fixed-dose combination of acetylsalicylic acid and clopidogrel compared with the concurrent administration of acetylsalicylic acid and clopidogrel in healthy subjects: a randomized, open-label, 2-sequence, 2-period, single-dose crossover study.
Jung JA; Kim TE; Kim JR; Kim MJ; Huh W; Park KM; Lee SY; Ko JW
Clin Ther; 2013 Jul; 35(7):985-94. PubMed ID: 23870608
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic and pharmacodynamic properties of eptifabatide in healthy subjects receiving unfractionated heparin or the low-molecular-weight heparin enoxaparin.
Gretler DD
Clin Ther; 2003 Oct; 25(10):2564-74. PubMed ID: 14667957
[TBL] [Abstract][Full Text] [Related]
32. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
Turpie AG; Bauer KA; Davidson BL; Fisher WD; Gent M; Huo MH; Sinha U; Gretler DD;
Thromb Haemost; 2009 Jan; 101(1):68-76. PubMed ID: 19132191
[TBL] [Abstract][Full Text] [Related]
33. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome.
Ng FH; Wong SY; Lam KF; Chang CM; Lau YK; Chu WM; Wong BC
Am J Gastroenterol; 2008 Apr; 103(4):865-71. PubMed ID: 18177451
[TBL] [Abstract][Full Text] [Related]
34. Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial.
Li Y; Jing Q; Wang B; Wang X; Li J; Qiao S; Chen S; Angiolillo DJ; Han Y
Am Heart J; 2020 Oct; 228():1-7. PubMed ID: 32739652
[TBL] [Abstract][Full Text] [Related]
35. Preservation of bioavailability of ingredients and lack of drug-drug interactions in a novel five-ingredient polypill (polycap): a five-arm phase I crossover trial in healthy volunteers.
Patel A; Shah T; Shah G; Jha V; Ghosh C; Desai J; Khamar B; Chakraborty BS
Am J Cardiovasc Drugs; 2010; 10(2):95-103. PubMed ID: 20334446
[TBL] [Abstract][Full Text] [Related]
36. Research on the mechanism of drug-drug interaction between salvianolate injection and aspirin based on the metabolic enzyme and PK-PD model: study protocol for a PK-PD trial.
Zhang W; Zhu B; Cao W; Li R; Wang S; Gao R
Trials; 2018 Sep; 19(1):491. PubMed ID: 30217228
[TBL] [Abstract][Full Text] [Related]
37. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.
Büller HR; Davidson BL; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob G; Segers AE; Cariou R; Leeuwenkamp O; Lensing AW;
Ann Intern Med; 2004 Jun; 140(11):867-73. PubMed ID: 15172900
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic and pharmacodynamic properties of batifiban coadministered with antithrombin agents in Chinese healthy volunteers.
He XM; Zhou Y; Li J; Wu SL; Jia MM; Liu MZ; Chen H; Chen K; Li SF; Wang YH; Li WY
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):786-790. PubMed ID: 24142738
[TBL] [Abstract][Full Text] [Related]
39. The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.
Dallob A; Luo WL; Luk JM; Ratcliffe L; Johnson-Levonas AO; Schwartz JI; Dishy V; Kraft WK; De Hoon JN; Van Hecken A; De Lepeleire I; Radziszewski W; Wagner JA; Lai E
Platelets; 2011; 22(7):495-503. PubMed ID: 21526889
[TBL] [Abstract][Full Text] [Related]
40. Lack of clinically significant pharmacological interactions between ticagrelor and enoxaparin or unfractionated heparin in healthy subjects.
Teng R; Butler K
J Clin Pharm Ther; 2012 Dec; 37(6):704-11. PubMed ID: 22747575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
